Nalmefene is effective at reducing alcohol seeking, treating alcohol‐cocaine interactions and reducing alcohol‐induced histone deacetylases gene expression in blood

BACKGROUND AND PURPOSE: The opioid antagonist nalmefene (selincro®) was approved for alcohol‐related disorders by the European Medicines Agency in 2013. However, there have been no studies regarding the effectiveness of nalmefene when alcohol is used in combination with cocaine. EXPERIMENTAL APPROAC...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Br J Pharmacol
Main Authors: Calleja‐Conde, Javier, Echeverry‐Alzate, Victor, Giné, Elena, Bühler, Kora‐Mareen, Nadal, Roser, Maldonado, Rafael, Rodríguez de Fonseca, Fernando, Gual, Antoni, López‐Moreno, Jose Antonio
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley and Sons Inc. 2016
נושאים:
Research Papers
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4959953/
https://ncbi.nlm.nih.gov/pubmed/27238566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13526
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים